Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong
Contact Us
US: +1 512 898-9222
SG: +65 3138-4148
EMAIL: Inquiry@asiaactual.com
Important Documents and Links
New Regulatory Documentation Exemptions in Thailand
Published: April 12th, 2024
On March 12th, 2024, the Thai FDA released draft guidance stating their intention to update the list of required documentation for Full and Concise Evaluation. For manufacturers registering qualifying medical devices in Thailand, certain documents will no longer be required. Thailand has three regulatory pathways:
- Full Evaluation (CSDT)
- Concise Evaluation (expedited review program)
- Singapore Reliance Program (expedited review program)
Only Full and Concise Evaluations will be impacted by this draft.
Full and Concise Documentation Exemptions
Full Evaluations will no longer require;
- Letter of certification of the intended use/indication/packaging, Letter of certification of label and instruction for use from manufacturer or product owner
- Safety declaration
- Marketing history declaration
- Proof of approval from authority in foreign countries
Concise Evaluation will no longer require;
- Design verification and validation documents
- Risk analysis
- Destruction method
Medical devices and IVDs that qualify for a Concise evaluation will receive an expedited review. To see whether your medical device or IVD qualifies for a concise evaluation, visit our blog post about concise evaluations in Thailand here.
With regards to questions or comments, feel free to contact Asia Actual today.
Come Grow with Us
Please contact Asia Actual with any questions or requests for support in Thailand. We have offices staffed by experienced, bilingual regulatory and commercial professionals in the major capital cities of Asia. Our mission is to provide a stable, reliable local platform so that our clients can grow their sales in challenging Asian markets.